Literature DB >> 18294355

Decreased factor XII activity is associated with recurrent IVF-ET failure.

Hidehiko Matsubayashi1, Toshitaka Sugi, Takahiro Suzuki, Noa Uchida, Haruyo Atsumi, Shun-ichiro Izumi, Mikio Mikami.   

Abstract

PROBLEM: A decrease in factor XII (FXII) activity has been observed in women with unexplained recurrent miscarriages. Because of the many similarities between recurrent in vitro fertilization-embryo transfer (IVF-ET) failure and early pregnancy loss patients, we investigated whether women with recurrent IVF-ET failure had low FXII activity. METHOD OF STUDY: Blood from 110 patients with three or more IVF-ET failures was tested for FXII activity, autoantibodies and other coagulation parameters. These patients were compared with 191 recurrent miscarriage patients, 87 controls. FXII activity was measured by an activated partial thromboplastin time (APTT) assay.
RESULTS: Factor XII activity of the IVF-ET failure group (median 79.5, range 37-150) was significantly lower than that of control group (median 109, range 35-225, P < 0.001 by Mann-Whitney test) or that of recurrent pregnancy loss (RPL) group (median 92, range 20-205). The FXII activity of IVF-ET failure patients was positively correlated with age, but not associated with the number of IVF-ET failures, infertile duration, autoantibodies, or other coagulation parameters.
CONCLUSION: Decreased FXII activity may causally relate to reproductive failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18294355     DOI: 10.1111/j.1600-0897.2007.00564.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  3 in total

Review 1.  Autoantibodies and coagulation in reproductive medicine.

Authors:  Hidehiko Matsubayashi
Journal:  Reprod Med Biol       Date:  2009-07-18

2.  Factor XII (Hageman) levels in women with recurrent pregnancy loss.

Authors:  A Seval Ozgu-Erdinc; Cihan Togrul; Ayla Aktulay; Umran Buyukkagnici; Elif Gul Yapar Eyi; Salim Erkaya
Journal:  J Pregnancy       Date:  2014-11-12

3.  Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates.

Authors:  Michael Wallisch; Christina U Lorentz; Hari H S Lakshmanan; Jennifer Johnson; Marschelle R Carris; Cristina Puy; David Gailani; Monica T Hinds; Owen J T McCarty; András Gruber; Erik I Tucker
Journal:  Res Pract Thromb Haemost       Date:  2020-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.